BiotechTube
Home/Tempo Therapeutics/Westbrook Weaver, PhD
WW

Westbrook Weaver, PhD

Founder & CEO

Tempo Therapeutics

Therapeutic Areas

Surgical OncologySoft Tissue ReconstructionWound Healing

Tempo Therapeutics Pipeline

DrugIndicationPhase
MAP Biosurgery Product (e.g., TT101)Soft tissue reconstruction (Dermal and Abdominal Wall)Pre-clinical

Leadership Team at Tempo Therapeutics

DG
Donald Griffin, PhD
Founder & CSO
SD
Stephanie Deshayes, PhD
VP R&D
KU
Kwame Ulmer
Chief Regulatory Officer
TS
Tatiana Segura, PhD
Founder, Scientific Advisor
View full Tempo Therapeutics profile